Pipeline — registered trials by phase
Project STARFISH - PRJ0002679
— · SARS-CoV-2 Infection, Influenza A, Influenza Type B · Completed · est. 2024-04-02
Stability of Tacrolimus, Cyclosporine A, Everolimus and Sirolimus in Whole Blood Patient Samples
— · Transplantation Drugs Stability · Completed · est. 2022-07-26
Butterfly - Clinical Performance Study
— · COVID-19, Coronavirus Infections · Completed · est. 2023-08-10
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Thermo Fisher is lead sponsor; 3 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 10-Q2026-07-31Quarterly report
- 8-K2026-07-23Current report (material event)
- 11-K2026-06-2311-K
- SD2026-05-28SD
- 8-K2026-05-26Current report (material event)
- DEFA14A2026-05-11DEFA14A
- 10-Q2026-05-01Quarterly report
- SCHEDULE 13G2026-04-30SCHEDULE 13G
- 8-K2026-04-23Current report (material event)
- ARS2026-04-07Annual report to holders
- DEFA14A2026-04-07DEFA14A
- DEF 14A2026-04-07Proxy statement
- SCHEDULE 13G/A2026-03-27SCHEDULE 13G/A
- 8-K2026-03-24Current report (material event)
- 10-K2026-02-26Annual report
- 8-K2026-02-12Current report (material event)
- 424B52026-02-10Prospectus (offering)
- FWP2026-02-09FWP
- 424B52026-02-09Prospectus (offering)
- 8-K2026-01-29Current report (material event)
- 25-NSE2026-01-2325-NSE
- 25-NSE2026-01-2125-NSE
- 8-K2026-01-12Current report (material event)
- CERT2025-12-08CERT
- 8-A12B2025-12-018-A12B
- 8-K2025-12-01Current report (material event)
- 424B52025-11-25Prospectus (offering)
- FWP2025-11-24FWP
- 424B52025-11-24Prospectus (offering)
- 10-Q2025-10-31Quarterly report
- 8-K2025-10-29Current report (material event)
- 8-K2025-10-22Current report (material event)
- 8-K2025-10-07Current report (material event)
- 424B52025-10-01Prospectus (offering)
- FWP2025-09-30FWP
- 424B52025-09-30Prospectus (offering)
- 8-K2025-09-02Current report (material event)
- 10-Q2025-08-01Quarterly report
- 8-K2025-07-23Current report (material event)
- 8-K2025-07-23Current report (material event)
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.